Catamaran (CTRX) jumps as OptumRx buys

Catamaran Corporation CTRX shares grew 24% to $59.90, on word the company and OptumRx have agreed to combine. OptumRx is UnitedHealth Group's free-standing pharmacy care services business. The agreement calls for the acquisition of Catamaran's outstanding common stock for $61.50 per share in cash. Share volume was 24.4 million, compared to an all-day average of 1.7 million
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!